Safety and Efficacy of Combination Maintenance Therapy with Ixazomib and Lenalidomide in Patients with Posttransplant Myeloma

PURPOSE: In this study, the addition of ixazomib to lenalidomide maintenance post-autologous stem cell transplant (ASCT) in 64 patients with newly diagnosed multiple myeloma was evaluated on the basis of the observed benefit of lenalidomide-only maintenance in prior studies. PATIENTS AND METHODS: Pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Krina K., Shah, Jatin J., Feng, Lei, Lee, Hans C., Manasanch, Elisabet M., Olsem, Jasper, Morphey, Ashley, Huo, Xiao Jiao, Thomas, Sheeba K., Bashir, Qaiser, Qazilbash, Muzaffar H., Weber, Donna M., Orlowski, Robert Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2022
Materias:
Clinical Trials: Targeted Therapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365361/
https://www.ncbi.nlm.nih.gov/pubmed/34992070
http://dx.doi.org/10.1158/1078-0432.CCR-21-3420

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365361/
https://www.ncbi.nlm.nih.gov/pubmed/34992070
http://dx.doi.org/10.1158/1078-0432.CCR-21-3420

Ejemplares similares